IV Therapy Market Research Report 2023
IV Therapy Market Size By Type (Implantable Ports, Intravenous Catheters, Hypodermic Needles, Infusion Pumps, Other), Medical Application (Volume Expander, Medication Administration, Blood Based Products, Nutrition and Buffer Solution), End User (Hospitals, Ambulatory Surgical Center, Clinics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels), Region- Global Market Analysis and Forecast, 2023- 2030
IV Therapy Market Synopsis
IV Therapy Market Size Was Valued at USD 47.5 Billion in 2022 and is Projected to Reach USD 78.9 Billion by 2030, Growing at a CAGR of 6.70% From 2023-2030.
IV or intravenous therapy is a way to give fluids, medicine, nutrition, or blood directly into the blood stream through a vein. IV therapy uses a type of tiny plastic tubing (cannula) that goes into the vein, a needle, and plastic tubing that connects the set-up to a bag of fluid. All together, the pieces are called an “IV.”
- The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not—due to reduced mental states or otherwise—consume food or water by mouth.
- The intravenous route is the fastest way to deliver medications and fluid replacement throughout the body as they are introduced directly into the circulatory system and thus quickly distributed. For this reason, the intravenous route of administration is also used for the consumption of some recreational drugs.
- Many therapies are administered as a "bolus" or one-time dose, but they may also be administered as an extended infusion or drip. The act of administering a therapy intravenously, or placing an intravenous line ("IV line") for later use, is a procedure which should only be performed by a skilled professional.
- The most basic intravenous access consists of a needle piercing the skin and entering a vein which is connected to a syringe or to external tubing. This is used to administer the desired therapy.
- Intravenous (IV) access is used to administer medications and fluid replacement which must be distributed throughout the body, especially when rapid distribution is desired. Another use of IV administration is the avoidance of first-pass metabolism in the liver.
Top Key Players Involved Are:
"BioScrip Inc. (US),Option Care Health Inc. (US),Coram LLC (US), BriovaRx (US), PharMerica Corporation (US), Amsino International Inc. (US), BioLife Plasma Services (US),Cigna Corporation (US),CVS Health Corporation (US),Express Scripts Holding Company (US),Diplomat Pharmacy Inc. (US),Walgreens Boots Alliance Inc. (US),AmerisourceBergen Corporation (US),Baxter International Inc. (US), B. Braun Melsungen AG (Germany), Fresenius SE & Co. KGaA (Germany),Terumo Corporation (Japan), Nipro Corporation (Japan), Smiths Medical (United Kingdom), Grifols S.A. (Spain)".
IV Therapy Market Trend Analysis
Ensure Proper Medication Administration
- IV medications bypass the digestive system and are delivered directly into the bloodstream, resulting in a rapid onset of action. This is particularly important in emergency situations or when immediate therapeutic effects are required.
- IV therapy allows healthcare professionals to accurately control and adjust medication dosages. The infusion rate can be carefully regulated, ensuring that the desired concentration and therapeutic effect are achieved.
- IV administration offers high bioavailability, meaning a larger proportion of the medication reaches the intended target site compared to other routes of administration. This is especially crucial for medications with low oral bioavailability or those that undergo extensive first-pass metabolism.
- IV therapy permits the continuous administration of medications over an extended period. This is particularly valuable for medications that require a consistent and sustained therapeutic effect, such as certain antibiotics or pain management medications.
- IV therapy allows for the simultaneous administration of multiple medications, as long as they are compatible. This is particularly advantageous in critical care settings or for patients requiring complex treatment regimens. Thus, proper medication helps to maintain the health and these factors responsible to increasing growth for the IV therapy market.
Increasing Awareness and Improving Access to IV Therapy
- Developing countries often face significant healthcare challenges, including limited access to medications and treatments. Raising awareness about the benefits and availability of IV therapy can help address these challenges by providing a safe and effective means of delivering essential medications and fluids directly into the bloodstream.
- IV therapy can be a critical component in treating various conditions, such as severe infections, dehydration, malnutrition, and chronic illnesses. Increasing awareness about IV therapy in developing countries can lead to improved treatment outcomes and reduced mortality rates, particularly in areas where alternative treatment options are limited.
- Maternal and child health is a significant concern in many developing countries. IV therapy can be instrumental in providing necessary medications, fluids, and nutrients during pregnancy, childbirth, and neonatal care. Increasing awareness about IV therapy in this context can help improve maternal and child health outcomes.
- Developing countries often face emergencies and natural disasters that require immediate medical attention. IV therapy can be crucial in providing life-saving treatments, such as fluid resuscitation, blood transfusions, and administration of medications. Raising awareness about the importance of IV therapy in emergency situations can help save lives and improve disaster response capabilities.
- In developing countries with high prevalence rates of infectious diseases, such as HIV/AIDS and malaria, IV therapy can play a vital role in preventing disease transmission. By ensuring sterile practices and promoting awareness about the importance of safe IV administration, the risk of infection can be minimized. Thus, the increasing awareness about the IV therapy is creating major opportunity for the IV therapy Market.
Source: Statista
In the above mentioned graph, the total number of hospitals states that Colombia has more number of hospitals as compared to other countries, followed by Japan, US, Mexico, Korea. In this way more access can be generated towards IV market.
Segmentation Analysis of IV Therapy Market
The IV Therapy Market segment covers the Type, Medical Application, End User, Distribution Channel. In End User, Hospitals segment is Anticipated to Dominate the Market Over the Forecast period.
- Hospitals play a crucial role in administering IV therapy to patients who require intravenous medications, fluids, blood products, and nutrients. Hospitals are equipped to handle complex medical cases that often require IV therapy.
- Patients with critical illnesses, surgeries, severe infections, or conditions requiring intensive care may require intravenous treatments. Hospitals have the necessary infrastructure, medical staff, and expertise to provide comprehensive IV therapy in these cases.
- Hospitals have access to specialized equipment and facilities required for IV therapy, such as infusion pumps, IV lines, sterile environments, and monitoring systems. These resources ensure the safe and effective administration of IV treatments to patients.
- Hospitals have multidisciplinary healthcare teams that include doctors, nurses, pharmacists, and other healthcare professionals with expertise in IV therapy. This collaboration ensures that patients receive appropriate and personalized IV treatments based on their medical condition.
Regional Analysis Of IV Therapy Market
North America Is Expected To Dominate the Market over the Forecast Period.
- North America, particularly the United States and Canada, has well-developed healthcare infrastructure, including hospitals, clinics, and healthcare systems. This infrastructure supports the delivery of IV therapy services and facilitates the availability of IV medications, equipment, and skilled healthcare professionals.
- North America is often at the forefront of technological advancements in the healthcare industry. This includes the development and adoption of advanced IV therapy equipment, such as infusion pumps, smart devices, and electronic health records (EHR) systems, which enhance the efficiency and safety of IV therapy administration.
- North America is home to several major pharmaceutical companies that produce a wide range of IV medications and solutions. The presence of these pharmaceutical companies contributes to the availability and accessibility of IV therapy products in the region.
- North America has stringent regulatory standards and guidelines for healthcare practices, including IV therapy. These regulations help ensure patient safety, quality control, and proper administration of IV treatments.
Covid 19 Impact Analysis On IV Therapy Market
- The COVID-19 pandemic resulted in a surge in hospitalizations, particularly among severe and critically ill patients. Many COVID-19 patients required intravenous treatments, such as fluids, medications and respiratory support, driving an increased demand for IV therapy.
- The global pandemic caused disruptions in the global supply chain, impacting the availability of IV therapy products and equipment. Factors such as transportation restrictions, manufacturing delays, and increased demand led to challenges in sourcing and distributing IV therapy supplies, creating temporary shortages in some regions.
- The pandemic prompted a shift in healthcare settings, with a focus on managing COVID-19 patients in specialized facilities such as temporary field hospitals and dedicated COVID-19 treatment centers.
- To minimize the risk of transmission and ease the burden on healthcare facilities, telemedicine and home healthcare services saw increased adoption during the pandemic. IV therapy providers started offering remote monitoring, consultations, and in-home IV therapy services to minimize hospital visits for patients who required ongoing infusion therapy.
Top Key Players Covered In The IV Therapy Market
- BioScrip Inc. (US)
- Option Care Health Inc. (US)
- Coram LLC (US)
- BriovaRx (US)
- PharMerica Corporation (US)
- Amsino International Inc. (US)
- BioLife Plasma Services (US)
- Cigna Corporation (US)
- CVS Health Corporation (US)
- Express Scripts Holding Company (US)
- Diplomat Pharmacy Inc. (US)
- Walgreens Boots Alliance Inc. (US)
- AmerisourceBergen Corporation (US)
- Baxter International Inc. (US)
- Braun Melsungen AG (Germany)
- Fresenius SE & Co. KGaA (Germany)
- Terumo Corporation (Japan)
- Nipro Corporation (Japan)
- Smiths Medical (United Kingdom)
- Grifols S.A. (Spain)
Key Industry Development In The IV Therapy Market
In April 2023, PharMerica Partners with SIRUM to Donate Unused, Unexpired Drugs to help under-resourced families' access life-saving medications. PharMerica has partnered with SIRUM since 2015 to donate unused, unexpired drugs.
In Jan 2020, Cigna, a leading global health service company, and Oscar, a tech-driven health insurance company, announced an exclusive partnership to jointly provide commercial health solutions to small businesses.
|
Global IV Therapy Market |
|||
|
Base Year: |
2022 |
Forecast Period: |
2023-2030 |
|
Historical Data: |
2016 to 2022 |
Market Size in 2021: |
USD 47560 Mn. |
|
Forecast Period 2022-30 CAGR: |
6.70% |
Market Size in 2030: |
USD 78900 Mn. |
|
Segments Covered: |
By Type |
|
|
|
By Medical Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Global IV Therapy Market |
|||
|
Base Year: |
2022 |
Forecast Period: |
2023-2030 |
|
Historical Data: |
2016 to 2022 |
Market Size in 2021: |
USD 47560 Mn. |
|
Forecast Period 2022-30 CAGR: |
6.70% |
Market Size in 2030: |
USD 78900 Mn. |
|
Segments Covered: |
By Type |
|
|
|
By Medical Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By By Type
3.2 By Medical Application
3.3 By End User
3.4 By Distribution Channel
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
Frequently Asked Questions
What would be the forecast period in the IV Therapy Market research report?
The forecast period in the IV Therapy Market research report is 2023-2030.
Who are the key players in IV Therapy Market?
BioScrip Inc. (US),Option Care Health Inc. (US),Coram LLC (US), BriovaRx (US), PharMerica Corporation (US), Amsino International Inc. (US), BioLife Plasma Services (US),Cigna Corporation (US), CVS Health Corporation (US), Express Scripts Holding Company (US),Diplomat Pharmacy Inc. (US), Walgreens Boots Alliance Inc. (US),AmerisourceBergen Corporation (US), Baxter International Inc. (US),B. Braun Melsungen AG (Germany),Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Nipro Corporation (Japan), Smiths Medical (United Kingdom), Grifols S.A. (Spain) And Other Major Players.
What are the segments of the IV Therapy Market?
The IV Therapy Market is segmented into Type, Medical Application, End User, Distribution Channel and Region. By Type, the market is categorized into Implantable Ports, Intravenous Catheters, Hypodermic Needles, Infusion Pumps and Others. By Medical Application, the market categorized into Volume Expander, Medication Administration, Blood Based Products, Nutrition and Buffer Solution and Others. By End User, the Market Categorized into Hospitals, Ambulatory Surgical Center, Clinics and Others. By Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies and others. By Region, it is analyzed North America (Us, Canada, Mexico), Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest Of APAC), Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest Of SA).
What is the IV Therapy Market?
IV or intravenous therapy is a way to give fluids, medicine, nutrition, or blood directly into the blood stream through a vein. IV therapy uses a type of tiny plastic tubing (cannula) that goes into the vein, a needle, and plastic tubing that connects the set-up to a bag of fluid. All together, the pieces are called an “IV.” The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not—due to reduced mental states or otherwise—consume food or water by mouth.
How big is the IV Therapy Market?
The Global IV Therapy Market size was reasonably estimated to be approximately USD 47560 Million in 2023 and is poised to generate revenue over USD 78900 Million by the end of 2030, projecting a CAGR of around 6.70% from 2023 to 2030.
